Achieve Life Sciences, Inc.
NASDAQ: ACHV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard A. Stewart
- Employees
- 25
- Headquarters
- Vancouver, Canada
- IPO year
- 1995
- Market cap
- $544.1M
- Website
- https://www.achievelifesciences.com
Loading ACHV…
Loading profile data…Frequently asked questions about ACHV
What does Achieve Life Sciences, Inc. (ACHV) do?
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a natu...
Where does ACHV trade?
Achieve Life Sciences, Inc. (ACHV) trades on the NASDAQ Capital Market.
What sector is ACHV in?
Achieve Life Sciences, Inc. (ACHV) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Achieve Life Sciences, Inc.?
Richard A. Stewart is the chief executive officer of Achieve Life Sciences, Inc. (ACHV).
Where is Achieve Life Sciences, Inc. headquartered?
Achieve Life Sciences, Inc. is headquartered in Canada.
Does ACHV pay a dividend?
Achieve Life Sciences, Inc. (ACHV) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACHV go public?
Achieve Life Sciences, Inc. (ACHV) completed its initial public offering in 1995.